WALD

$1.56

Post-MarketAs of Mar 17, 8:00 PM UTC

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.56
Potential Upside
5%
Whystock Fair Value$1.64
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorConsumer Defensive
IndustryHousehold & Personal Products

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care produc...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$193.37M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.45
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-40.33%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.80

Recent News

TipRanks
Feb 26, 2026

Obagi Medical, It’s a Secret Med Spa collaborate for ALOHA program

Obagi Medical announced It’s a Secret Med Spa as a key partner in the Aesthetics Leadership with Obagi’s Hyaluronic Acid Program. It’s a Secret Med Spa will help generate real-world data to translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday practice across multiple locations and structured evaluation programs.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 23, 2026

How The Waldencast (WALD) Narrative Is Shifting As Outlook Resets Meet Brand Optimism

Waldencast’s fair value target is held at $3.08 per share, with no change between the prior and updated estimate. That steady target sits against a mixed analyst backdrop, where some highlight the Buy rating and long term brand potential, while others focus on weaker Q2 results, a reduced FY25 outlook and questions around execution. As you read on, you will see how to track this evolving story and what to watch as sentiment and assumptions shift over time. Analyst Price Targets don't always...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 7, 2026

How The Story Behind Waldencast (WALD) Is Shifting In Analysts’ Eyes

Why the Waldencast Price Target Has Shifted Waldencast’s consensus analyst price target has edged from about US$3.20 to about US$3.08, a small change that still reflects a split view between long term brand potential and questions about near term execution. The slightly higher discount rate of about 9.62% compared with about 8.73% and modestly stronger revenue growth assumptions of about 6.31% compared with about 6.17% capture this tension, with optimism around the brands tempered by cautious...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Nov 29, 2025

How Recent Developments Are Shaping the Waldencast Investment Story

Waldencast stock has recently seen its consensus analyst price target reduced from $3.50 to $3.20, reflecting a slightly less optimistic view on the company's fair value. This adjustment comes as analyst perspectives shift, with reduced risk to cash flows now anticipated and projections for future revenue growth being trimmed. Keep reading to discover how changes in analyst expectations may influence the narrative moving forward and how to stay informed as new developments unfold. Stay...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
24/7 Wall St.
Nov 25, 2025

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Applied Materials, CDW, Exact Sciences, Harley-Davidson, Oshkosh, ServiceNow and More

Pre-Market Stock Futures: The futures are lower on Tuesday after traders kicked off the holiday-shortened trading week with a massive Monday rally, with all major indices finishing the day higher. A combination of an oversold market, a big bounce-back rally on Friday that saw follow-through on Monday, and some positive AI/Data Center/Hyperscaler commentary to help ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Applied Materials, CDW, Exact Sciences, Harley-Davidson, Oshkosh, Serv

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.